DiaMedica Therapeutics Inc. financial data

Symbol
DMAC on Nasdaq
Industry
Pharmaceutical Preparations
Location
301 Carlson Parkway, Suite 210, Minneapolis, MN
State of incorporation
Canada (Federal Level)
Fiscal year end
December 31
Former names
DiaMedica Inc. (to 3/11/2014)
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.91K % +14.8%
Return On Equity -38.6 % +10.5%
Return On Assets -36.5 % +9.89%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 42.7M shares +12.6%
Common Stock, Shares, Outstanding 42.7M shares +12.5%
Entity Public Float 103M USD +96.2%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 38.1M shares +39.4%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 14.6M USD +44.5%
General and Administrative Expense 7.83M USD +7.39%
Operating Income (Loss) -22.4M USD -28.9%
Nonoperating Income (Expense) 1.93M USD +446%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -19.9M USD -20.1%
Income Tax Expense (Benefit) 43K USD +53.6%
Net Income (Loss) Attributable to Parent -19.9M USD -20.2%
Earnings Per Share, Basic -0.51 USD/shares +17.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 14.1M USD +141%
Marketable Securities, Current 40M USD +15.8%
Cash, Cash Equivalents, and Short-term Investments 54.1M USD -10.9%
Accounts Receivable, after Allowance for Credit Loss, Current 391K USD +108%
Assets, Current 55M USD +33.4%
Property, Plant and Equipment, Net 152K USD +14.3%
Operating Lease, Right-of-Use Asset 317K USD -18.7%
Assets 56.8M USD -8.48%
Accounts Payable, Current 759K USD -11.3%
Employee-related Liabilities, Current 473K USD -0.63%
Accrued Liabilities, Current 2.23M USD +120%
Liabilities, Current 3.09M USD +58.7%
Operating Lease, Liability, Noncurrent 272K USD +6700%
Accumulated Other Comprehensive Income (Loss), Net of Tax -51K USD +19%
Retained Earnings (Accumulated Deficit) -126M USD -18.8%
Stockholders' Equity Attributable to Parent 53.4M USD -10.6%
Liabilities and Equity 56.8M USD -8.48%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.65M USD -30.7%
Net Cash Provided by (Used in) Investing Activities 4.21M USD +67.7%
Common Stock, Shares, Issued 42.7M shares +12.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.45M USD +5.23%
Deferred Tax Assets, Valuation Allowance 28M USD +23.3%
Operating Lease, Liability 357K USD -17.6%
Depreciation 8K USD +14.3%
Payments to Acquire Property, Plant, and Equipment 9K USD +28.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -19.9M USD -20.9%
Lessee, Operating Lease, Liability, to be Paid 413K USD -20.7%
Property, Plant and Equipment, Gross 250K USD +12.6%
Operating Lease, Liability, Current 85K USD +2733%
Lessee, Operating Lease, Liability, to be Paid, Year Two 116K USD +2.66%
Lessee, Operating Lease, Liability, to be Paid, Year One 113K USD +3.67%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 56K USD -36.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 119K USD +2.59%
Deferred Tax Assets, Operating Loss Carryforwards 26M USD +24%
Lessee, Operating Lease, Liability, to be Paid, Year Four 10K USD -91.6%
Additional Paid in Capital 179M USD +8.18%
Deferred Tax Assets, Net of Valuation Allowance 28M USD +23.3%
Share-based Payment Arrangement, Expense 1.81M USD +11.1%